NFKB1 and inflammatory bowel disease: Activated NF-κB has been demonstrated in colonic epithelial cells and macrophages of patients with IBD [21, 22], and also NF-κB p65 antisense oligonucleotide treatment was reported to have much benefits in experimental colitis, although toxicity effects must be carefully analyzed [23, 24].